
Novartis wins approval: First malaria treatment drug for newborns and babies is here
For the first time in history, newborns and very young infants have access to a malaria treatment tailored to their unique needs. On July 8, Swissmedic – Switzerland’s regulatory agency – greenlit Coartem Baby (also known as Riamet Baby), marking a …